Lingzhi Xiao

Title: Innovations and Contributions of Inventor Lingzhi Xiao

Introduction

Lingzhi Xiao is a prominent inventor based in Rockville, MD, who has made significant contributions to the field of biotechnology. With a total of six patents to her name, she has focused her research on developing innovative solutions for cancer treatment and gene regulation.

Latest Patents

Among her latest patents is a vector system for expressing regulatory RNA. This invention involves viral vectors, lentiviral particles, and modified cells that encode or express a small RNA capable of targeting the KIF11 gene. In certain embodiments, the viral vectors and lentiviral particles include a modified KIF11 gene whose non-coding region is resistant to the small RNA's activity. Another notable patent is for combination vectors and methods for treating cancer. This composition includes a lentiviral particle and an aminobisphosphonate drug, specifically zoledronic acid. The lentiviral particle is designed to infect target cells, such as cancer cells, and includes an envelope protein optimized for targeting these cells, along with a viral vector that contains a small RNA optimized to target an FDPS mRNA sequence.

Career Highlights

Lingzhi Xiao is currently associated with American Gene Technologies International Inc., where she continues to advance her research and innovations. Her work has been instrumental in developing new therapeutic approaches that leverage gene therapy techniques.

Collaborations

Throughout her career, Lingzhi has collaborated with notable colleagues, including Tyler Lahusen and Charles David Pauza. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Lingzhi Xiao's innovative work in biotechnology, particularly in cancer treatment and gene regulation, showcases her dedication to advancing medical science. Her patents reflect her commitment to finding effective solutions for complex health challenges.